| Catalogue Number |
Products |
CAS No. |
Assay |
| LTJ056308 | N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1,5-dimethyl-1H-Pyrazole-3-carboxamide | 1198432-67-5 | |
| LTJ056309 | N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1-methyl-1H-Imidazole-4-carboxamide | 1198432-63-1 | |
| LTJ056310 | N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1-methyl-1H-Pyrrole-2-carboxamide | 1198432-61-9 | |
| LTJ056311 | N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1-methyl-1H-Imidazole-2-carboxamide | 1198432-59-5 | |
| LTJ056312 | N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-5-methyl-1H-Pyrazole-3-carboxamide | 1198432-57-3 | |
| LTJ056313 | 2-methyl-N-(1-(tetrahydro-2H-pyran-2-yl)-6-(4,4,6,6-tetramethyl-1,3,2-dioxaborinan-2-yl)-1H-indazol-4-yl)thiazole-4-carboxamide | 1310556-97-8 | |
| LTJ056314 | 2-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-5-(bromomethyl)-1,3,4-oxadiazole | 1245466-06-1 | |
| LTJ056315 | 1-(((5-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)amino)-3-morpholinopropan-2-ol | 1245465-51-3 | |
| LTJ056316 | 4-((5-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-2-ethylmorpholine | 1245465-43-3 | |
| LTJ056317 | 4-((5-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-1,4-oxazepane | 1245465-38-6 | |
| LTJ056318 | 4-((5-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-2-methylmorpholine | 1245465-37-5 | |
| LTJ056319 | 9-((5-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-6-oxa-9-azaspiro[4.5]decane | 1245465-34-2 | |
| LTJ056320 | N-(2-chloro-5-(4-(5-methyl-1,3,4-oxadiazol-2-yl)-1-tosyl-1H-indazol-6-yl)pyridin-3-yl)methanesulfonamide | 1245465-32-0 | |
| LTJ056321 | 6-(4,4,6,6-tetramethyl-1,3,2-dioxaborinan-2-yl)-1-tosyl-1H-indazole-4-carbonitrile | 1245465-31-9 | |
| LTJ056322 | 6-(1H-indol-4-yl)-1-tosyl-1H-indazole-4-carbonitrile | 1245465-23-9 | |
| LTJ056323 | 4-((5-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-2,2-dimethylmorpholine | 1245465-20-6 | |
| LTJ056324 | 2-(6-bromo-1-methyl-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)-1,3,4-oxadiazole | 1245465-19-3 | |
| LTJ056325 | 6-bromo-4-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]-1-methyl-1H-Indazole | 1245465-13-7 | |
| LTJ056326 | 2-(6-bromo-1-(phenylsulfonyl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)-1,3,4-oxadiazole | 1245465-01-3 | |
| LTJ056327 | 6-bromo-N’-(2-morpholinoacetyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole-4-carbohydrazide | 1245464-91-8 | |
| LTJ056328 | 6-bromo-N’-(2-morpholinoacetyl)-1H-indazole-4-carbohydrazide | 1245464-89-4 | |
| LTJ056329 | 4-((5-(6-bromo-1-tosyl-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)morpholine | 1245464-65-6 | |
| LTJ056330 | 2-(6-bromo-1-tosyl-1H-indazol-4-yl)-5-(chloromethyl)-1,3,4-oxadiazole | 1245464-60-1 | |
| LTJ056331 | 4-((5-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-2-methylmorpholine | 1245464-40-7 | |
| LTJ056332 | 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-((phenylsulfonyl)methyl)-1,3,4-oxadiazole | 1245464-16-7 | |
| LTJ056333 | 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-((methylsulfonyl)methyl)-1,3,4-oxadiazole | 1245464-15-6 | |
| LTJ056334 | N-[2-chloro-5-[4-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-indazol-6-yl]-3-pyridinyl]Methanesulfonamide | 1245464-14-5 | |
| LTJ056335 | 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-(methoxymethyl)-1,3,4-oxadiazole | 1245464-10-1 | |
| LTJ056336 | 5-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1,3,4-Oxadiazole-2-methanol | 1245464-07-6 | |
| LTJ056337 | 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-((benzyloxy)methyl)-1,3,4-oxadiazole | 1245464-05-4 | |
Product Search
